Macitentan Powder

Macitentan is a heterocyclic sulfonamide small molecule antagonist targeting dual endothelin receptors, built for investigating pulmonary vascular biology and vascular remodeling pathways. Its distinctive fused heterocyclic scaffold is widely applied to prepare DMSO stock solutions for endothelin receptor in-vitro cell models. Researchers utilize this raw powder to study endothelial cell functional regulation, construct pulmonary vascular remodeling cell models, assess photodegradation stability, and validate tablet formulation intermediates for pulmonary hypertension candidates.
When stored refrigerated, dry, sealed and protected from light in lab environments, this high-purity fine powder maintains consistent solubility after dissolving in polar organic solvent. It preserves uniform chemical properties in cell test matrices, offering reliable reference samples for receptor binding assays and photodegradation studies. It works well for early-stage anti-pulmonary hypertension solid formulation screening and heterocyclic small molecule structural modification exploration.

◆ In-vitro Endothelin Dual Receptor Antagonism Research
Serves as pharmacological additive inside cell incubation systems to evaluate endothelin receptor blocking effects during vascular endothelial cell pharmacological screening.

◆ Photodegradation Stability Assessment in Organic Solvent
Acts as certified reference substance to track light-induced degradation and impurity formation under varied illumination conditions within DMSO liquid reaction matrices.

◆ Heterocyclic Scaffold for Vascular Active Molecule Derivatization
Provides sulfonamide heterocyclic molecular backbone for synthetic chemistry labs, supporting derivative synthesis and structure–activity research of vascular therapeutic candidates.

◆ DMSO Stock Solution Preparation Compatibility
Dissolves readily in DMSO; can be combined with cell culture buffers to create multi-component working assay solutions for vascular cell experiments.